After being cocultured with UC-MSCs, we found that the reduced proportion of both CD19+CD24hiCD38hi and B10 cells of ITP increased significantly, suggesting UC-MSCs can induce immune tolerance in ITP treatment by mediating B cell subgroup changes. This evidence concerns the gene CD19 and autoimmune thrombocytopenic purpura.